Guggenheim now has 56 ETFs available on Schwab ETF OneSource, representing the program's largest number of product offerings with representation across asset classes including U.S. equity, international equity, U.S. fixed-income, sectors and currency
NEW YORK , Sept.
BERLIN , September 18, 2014 /PRNewswire/ -- Infosys , a global leader in technology, consulting and outsourcing, today announced a global partnership with Huawei , a leading global information and communication technology (ICT) solution provider.
- Quarterly cash dividend increases 5% to $0.85 per share - the equivalent of $3.40 annually - Returned $3.2 billion year-to-date August under the 2014-2016 $18 to $20 billion total cash return target
OAK BROOK, Ill.
- AUSTRALIA EXPECTED TO BENEFIT FROM RECENT CHINA COAL QUALITY POLICIES - INDIA COAL IMPORTS RISING FASTER THAN EXPECTED - PEABODY SIGNING SOUTHERN POWDER RIVER BASIN COAL SUPPLY AGREEMENTS AT LEVELS MATERIALLY ABOVE PUBLISHED INDICES
GOOSE CREEK, SC--(Marketwired - September 18, 2014) - ProFlight, a subsidiary of TRU Simulation + Training Inc., a Textron Inc. (NYSE: TXT) company, and a leader in innovative, advanced pilot training, announced today plans to open a flight training center early in 2015 in Tampa, Fla.
Drive-In (NASDAQ: SONC), the nation’s largest chain of drive-in
restaurants, presented the Troy Smith Hall of Fame Award to respected
franchisee Buddy McClain, chief executive officer of MVP Sonics at the
2014 SONIC National Convention last week in New Orleans.
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, and CASI Pharmaceuticals, Inc.
(Nasdaq: CASI), a biopharmaceutical company dedicated to the
acquisition, development and commercialization of innovative
therapeutics addressing cancer and other unmet medical needs for the
global market with a primary focus on China, announce the signing of
license agreements whereby CASI has been granted exclusive rights to two
of Spectrum Pharmaceuticals’ commercial oncology drugs, Zevalin®
(ibritumomab tiuxetan) Injection for intravenous use and Marqibo®
(vinCRIStine sulfate LIPOSOME injection) for intravenous infusion, and a
Phase 3 drug candidate, Captisol-Enabled™ Melphalan (CE melphalan), for
development and commercialization in China, including Taiwan, Hong Kong
For anyone taking notes (so to speak), T-Mobile (NYSE: TMUS )
today announced the Samsung Galaxy Note 4 will be available at
participating T-Mobile stores nationwide and online for $0 down (and
$31.24 a month for 24 months) starting October 17.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.